{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:22:01Z","timestamp":1793312521784,"version":"4.5.0"},"reference-count":25,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Individuals harboring inherited heterozygous germline mutations in BAP1 are predisposed to a range of benign and malignant tumor types, including malignant mesothelioma, melanoma, and kidney carcinoma. However, evidence to support a tumor-suppressive role for BAP1 in cancer remains contradictory. To test experimentally whether BAP1 behaves as a tumor suppressor, we monitored spontaneous tumor development in three different mouse models with germline heterozygous mutations in Bap1, including two models in which the knock-in mutations are identical to those reported in human BAP1 cancer syndrome families. We observed spontaneous malignant tumors in 54 of 93 Bap1-mutant mice (58%) versus 4 of 43 (9%) wild-type littermates. All three Bap1-mutant models exhibited a high incidence and similar spectrum of neoplasms, including ovarian sex cord stromal tumors, lung and mammary carcinomas, and spindle cell tumors. Notably, we also observed malignant mesotheliomas in two Bap1-mutant mice, but not in any wild-type animals. We further confirmed that the remaining wild-type Bap1 allele was lost in both spontaneous ovarian tumors and mesotheliomas, resulting in the loss of Bap1 expression. Additional studies revealed that asbestos exposure induced a highly significant increase in the incidence of aggressive mesotheliomas in the two mouse models carrying clinically relevant Bap1 mutations compared with asbestos-exposed wild-type littermates. Collectively, these findings provide genetic evidence that Bap1 is a bona fide tumor suppressor gene and offer key insights into the contribution of carcinogen exposure to enhanced cancer susceptibility. Cancer Res; 76(9); 2836\u201344. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-15-3371","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T23:04:06Z","timestamp":1455923046000},"page":"2836-2844","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline\n                    <i>Bap1<\/i>\n                    Mutations"],"prefix":"10.1158","volume":"76","author":[{"given":"Yuwaraj","family":"Kadariya","sequence":"first","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Cheung","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Xu","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Pei","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Sementino","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Menges","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy Q.","family":"Cai","sequence":"additional","affiliation":[{"name":"2Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Rauscher","sequence":"additional","affiliation":[{"name":"3Gene Expression and Regulation Program, Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres J.","family":"Klein-Szanto","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."},{"name":"2Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Testa","sequence":"additional","affiliation":[{"name":"1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,5,1]]},"reference":[{"key":"2022061706023932400_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.14694\/EdBook_AM.2013.33.81","article-title":"Connecting molecular pathways to hereditary cancer risk syndromes","author":"Testa","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2022061706023932400_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2022061706023932400_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"2022061706023932400_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"2022061706023932400_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"2022061706023932400_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"2022061706023932400_bib7","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"2022061706023932400_bib8","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J Clin Oncol"},{"key":"2022061706023932400_bib9","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"2022061706023932400_bib10","doi-asserted-by":"crossref","first-page":"e72144","DOI":"10.1371\/journal.pone.0072144","article-title":"A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers","volume":"8","author":"Aoude","year":"2013","journal-title":"PLoS One"},{"key":"2022061706023932400_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","author":"Cheung","year":"2013","journal-title":"Cancer Genet"},{"key":"2022061706023932400_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma","volume":"88","author":"Wadt","year":"2015","journal-title":"Clin Genet"},{"key":"2022061706023932400_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canlet.2015.09.011","article-title":"Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction","volume":"369","author":"Cheung","year":"2015","journal-title":"Cancer Lett"},{"key":"2022061706023932400_bib14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706023932400_bib15","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"2022061706023932400_bib16","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"key":"2022061706023932400_bib17","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","author":"Napolitano","journal-title":"Oncogene."},{"key":"2022061706023932400_bib18","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1038\/ncomms9471","article-title":"BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5","volume":"6","author":"Qin","year":"2015","journal-title":"Nat Commun"},{"key":"2022061706023932400_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"2022061706023932400_bib20","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1073\/pnas.1009424107","article-title":"Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases","volume":"107","author":"Meyer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706023932400_bib21","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","article-title":"A mouse model recapitulating molecular features of human mesothelioma","volume":"65","author":"Altomare","year":"2005","journal-title":"Cancer Res"},{"key":"2022061706023932400_bib22","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1073\/pnas.0808816106","article-title":"Activated TNF-alpha\/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice","volume":"106","author":"Altomare","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706023932400_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors","volume":"12","author":"McClatchey","year":"1998","journal-title":"Genes Dev"},{"key":"2022061706023932400_bib24","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.96.11.6382","article-title":"p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice","volume":"96","author":"Park","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706023932400_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ygyno.2011.03.020","article-title":"Patterns of spread and recurrence of sex cord-stromal tumors of the ovary","volume":"122","author":"Thrall","year":"2011","journal-title":"Gynecol Oncol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/9\/2836\/2750522\/2836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/9\/2836\/2750522\/2836.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:50:12Z","timestamp":1655470212000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/9\/2836\/618779\/Bap1-Is-a-Bona-Fide-Tumor-Suppressor-Genetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,5,1]]},"published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-15-3371","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6508683.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413318","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413318.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413321.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413321","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413324","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413324.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508683","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}